These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 15854809

  • 1. A comparative study of the potential of solid triglyceride nanostructures coated with chitosan or poly(ethylene glycol) as carriers for oral calcitonin delivery.
    Garcia-Fuentes M, Prego C, Torres D, Alonso MJ.
    Eur J Pharm Sci; 2005 May; 25(1):133-43. PubMed ID: 15854809
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Enhancement of oral bioavailability of salmon calcitonin through chitosan-modified, dual drug-loaded nanoparticles.
    Liu L, Yang H, Lou Y, Wu JY, Miao J, Lu XY, Gao JQ.
    Int J Pharm; 2019 Feb 25; 557():170-177. PubMed ID: 30597264
    [Abstract] [Full Text] [Related]

  • 5. New surface-modified lipid nanoparticles as delivery vehicles for salmon calcitonin.
    Garcia-Fuentes M, Torres D, Alonso MJ.
    Int J Pharm; 2005 May 30; 296(1-2):122-32. PubMed ID: 15885464
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Improved intestinal delivery of salmon calcitonin by Lys18-amine specific PEGylation: stability, permeability, pharmacokinetic behavior and in vivo hypocalcemic efficacy.
    Youn YS, Jung JY, Oh SH, Yoo SD, Lee KC.
    J Control Release; 2006 Sep 12; 114(3):334-42. PubMed ID: 16884808
    [Abstract] [Full Text] [Related]

  • 8. The use of polyion complex micelles to enhance the oral delivery of salmon calcitonin and transport mechanism across the intestinal epithelial barrier.
    Li N, Li XR, Zhou YX, Li WJ, Zhao Y, Ma SJ, Li JW, Gao YJ, Liu Y, Wang XL, Yin DD.
    Biomaterials; 2012 Dec 12; 33(34):8881-92. PubMed ID: 22975427
    [Abstract] [Full Text] [Related]

  • 9. Chitosan nanocapsules as carriers for oral peptide delivery: effect of chitosan molecular weight and type of salt on the in vitro behaviour and in vivo effectiveness.
    Prego C, Torres D, Alonso MJ.
    J Nanosci Nanotechnol; 2006 Dec 12; 6(9-10):2921-8. PubMed ID: 17048499
    [Abstract] [Full Text] [Related]

  • 10. Oral absorption enhancement of salmon calcitonin by using both N-trimethyl chitosan chloride and oligoarginines-modified liposomes as the carriers.
    Huang A, Su Z, Li S, Sun M, Xiao Y, Ping Q, Deng Y.
    Drug Deliv; 2014 Aug 12; 21(5):388-96. PubMed ID: 24188463
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Biodegradable nanoparticles containing protein-fatty acid complexes for oral delivery of salmon calcitonin.
    Sang Yoo H, Gwan Park T.
    J Pharm Sci; 2004 Feb 12; 93(2):488-95. PubMed ID: 14705204
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
    Bagre AP, Jain K, Jain NK.
    Int J Pharm; 2013 Nov 01; 456(1):31-40. PubMed ID: 23994363
    [Abstract] [Full Text] [Related]

  • 17. Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells.
    Sadeghi AM, Dorkoosh FA, Avadi MR, Weinhold M, Bayat A, Delie F, Gurny R, Larijani B, Rafiee-Tehrani M, Junginger HE.
    Eur J Pharm Biopharm; 2008 Sep 01; 70(1):270-8. PubMed ID: 18492606
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. PHEA-graft-polymethacrylate supramolecular aggregates for protein oral delivery.
    Licciardi M, Pasut G, Amato G, Scialabba C, Mero A, Montopoli M, Cavallaro G, Schiavon O, Giammona G.
    Eur J Pharm Biopharm; 2013 May 01; 84(1):21-8. PubMed ID: 23275110
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.